GE also has an important effect on reducing neuronal loss and apoptosis in AD, and this process is achieved mainly through activation of the PI3K/AKT/mTOR pathway, suppression of the NLRP3/NF‐κB pathway and the release of the apoptotic proteins Bcl‐2 and Bax [118]. This evidence concerns the gene AKT1 and Alzheimer disease.